CIBC Private Wealth Group
COGT icon

CIBC Private Wealth Group’s Cogent Biosciences COGT Stock Holding History

CIBC Private Wealth Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.24K Buy
+35
New +$984 ﹤0.01% 2878

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIBC Private Wealth Group's COGT Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Cogent Biosciences (COGT) in Q4 2025: 35 shares worth $1.24K. The stake represents ﹤0.01% of the portfolio and ranks #2878 among its holdings.

267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • CIBC Private Wealth Group held 35 shares of Cogent Biosciences worth $1.24K as of Q4 2025.
  • Cogent Biosciences was a new CIBC Private Wealth Group position in Q4 2025.
  • Cogent Biosciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2878 holding.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.